Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M11,233Revenue $M7,435Net Margin (%)7.5Z-Score3.1
Enterprise Value $M14,832EPS $3.8Operating Margin %13.2F-Score6
P/E(ttm))20.6Cash Flow Per Share $5.2Pre-tax Margin (%)11.4Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %7.1Quick Ratio0.9Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %3.6Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow11.3y-y EBITDA Growth Rate %-22.4ROA % (ttm)5.8Higher Current Ratio y-yN
Dividend Yield %1.7Insider Buy (3m)0ROE % (ttm)13.6Less Shares Outstanding y-yY
Payout Ratio %26.0Shares Outstanding M144ROI % (ttm)5.5Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXJohn Hussman 2014-12-31 Buy 1.3%$57.71 - $68.1
($63.08)
$ 77.8419%New holding200,000
DGXRobert Olstein 2014-12-31 Reduce-0.18%$57.71 - $68.1
($63.08)
$ 77.8419%Reduce -28.05%59,000
DGXCharles Brandes 2014-12-31 Buy 0.18%$57.71 - $68.1
($63.08)
$ 77.8419%New holding186,113
DGXRichard Pzena 2014-12-31 Sold Out -0.14%$57.71 - $68.1
($63.08)
$ 77.8419%Sold Out0
DGXHOTCHKIS & WILEY 2014-12-31 Reduce-0.13%$57.71 - $68.1
($63.08)
$ 77.8419%Reduce -38.25%983,900
DGXJoel Greenblatt 2014-12-31 Reduce-0.09%$57.71 - $68.1
($63.18)
$ 77.8419%Reduce -62.94%88,219
DGXRay Dalio 2014-12-31 Add0.02%$57.71 - $68.1
($63.08)
$ 77.8419%Add 239.98%53,126
DGXHOTCHKIS & WILEY 2014-09-30 Reduce-0.19%$59.28 - $64.08
($61.73)
$ 77.8421%Reduce -36.86%1,593,262
DGXJoel Greenblatt 2014-09-30 Add0.14%$59.28 - $64.08
($61.73)
$ 77.8421%Add 5330.13%238,057
DGXChris Davis 2014-06-30 Add0.8%$55.5 - $61.75
($58.56)
$ 77.8425%Add 4465.97%4,672,681
DGXRichard Pzena 2014-06-30 Reduce-0.18%$55.5 - $61.75
($58.56)
$ 77.8425%Reduce -55.66%431,100
DGXRobert Olstein 2014-06-30 Reduce-0.14%$55.5 - $61.75
($58.56)
$ 77.8425%Reduce -18.00%82,000
DGXDavid Dreman 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 77.8425%Reduce -26.19%35,982
DGXJoel Greenblatt 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 77.8425%Reduce -94.26%4,384
DGXRay Dalio 2014-06-30 Reduce-0.03%$55.5 - $61.75
($58.56)
$ 77.8425%Reduce -82.85%13,545
DGXJoel Greenblatt 2014-03-31 Reduce-0.26%$50.8 - $57.99
($53.53)
$ 77.8431%Reduce -72.63%76,412
DGXHOTCHKIS & WILEY 2014-03-31 Add0.1%$50.8 - $57.99
($53.53)
$ 77.8431%Add 23.69%2,495,500
DGXDavid Dreman 2014-03-31 Add0.09%$50.8 - $57.99
($53.53)
$ 77.8431%Add 66.84%48,748
DGXRay Dalio 2014-03-31 Buy 0.04%$50.8 - $57.99
($53.53)
$ 77.8431%New holding78,977
DGXChris Davis 2014-03-31 Buy 0.02%$50.8 - $57.99
($53.53)
$ 77.8431%New holding102,337
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PREVOZNIK MICHAEL ESVP & General Counsel 2015-03-03Sell3,261$71.166.62view
GUINAN MARKSenior Vice President & CFO 2015-02-17Sell280$71.745.76view
PREVOZNIK MICHAEL ESVP & General Counsel 2015-02-17Sell488$71.416.25view
STANZIONE DANIELDirector 2015-02-11Sell8,000$70.976.9view
WILENSKY GAIL RDirector 2015-02-04Sell8,000$72.344.88view
PFEIFFER GARY MDirector 2015-02-04Sell8,000$72.434.75view
ZIEGLER JOHN BDirector 2015-02-03Sell8,000$71.885.55view
BONGIORNO THOMAS FVP and Corporate Controller 2015-02-02Sell3,000$71.56.11view
BONGIORNO THOMAS FVP and Corporate Controller 2014-11-18Sell10,000$6418.55view
Cohen Jon RSVP and Chief Medical Officer 2014-11-17Sell160,029$63.1320.18view

Press Releases about DGX :

    Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    Vermillion (VRML) Ovarian Cancer Test Mega-deal; Papa Murphy's Holdings (FRSH) and Wix (WIX) Strong Mar 18 2015 
    Charles Brandes' Top Buys During Q4 Feb 11 2015 
    A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
    DGX: A Healthy Diagnosis Oct 08 2014 
    The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 05 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
    Bernard Horn Comments on Quest Diagnostics Aug 07 2014 
    Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 


    More From Other Websites
    Deutsche Bank Is Downgrading Quest Diagnostics, But Notes 4 Key Upside Catalysts Mar 25 2015
    The Zacks Analyst Blog Highlights: Natus Medical, Mead Johnson Nutrition, Amedisys, Quest... Mar 23 2015
    Bulls bet Quest will hit new highs Mar 23 2015
    Diabetes Diagnoses Surge in States that Expanded Medicaid Under the Affordable Care Act Mar 23 2015
    Diabetes Diagnoses Surge in States that Expanded Medicaid Under the Affordable Care Act Mar 23 2015
    International Day of Happiness: Stocks to Make You Smile - Analyst Blog Mar 20 2015
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 19 2015
    Quest Diagnostics Announces Early Tender Date Results of Cash Tender Offers for Up to $250 Million... Mar 19 2015
    Quest Diagnostics Announces Early Tender Date Results of Cash Tender Offers for Up to $250 Million... Mar 19 2015
    Big Data Has Big Potential For HealthTap's New Healthcare Chief Mar 19 2015
    Quest Diagnostics Announces Pricing of Cash Tender Offers for Up to $250 Million Combined Aggregate... Mar 18 2015
    Quest Diagnostics Announces Pricing of Cash Tender Offers for Up to $250 Million Combined Aggregate... Mar 18 2015
    FormFactor, Lands' End, Avista, Chesapeake Utilities and Quest Diagnostics highlighted as Zacks Bull... Mar 17 2015
    3 Top-Ranked Low-Beta Stocks to Cushion Your Portfolio - Analyst Blog Mar 16 2015
    Quest Diagnostics' New Pediatric Neurological Disorder Test - Analyst Blog Mar 12 2015
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Mar 10 2015
    Quest Diagnostics to Enhance Diagnosis of Pediatric Neurological Disorders with Exclusive Whole... Mar 10 2015
    Quest Diagnostics to Enhance Diagnosis of Pediatric Neurological Disorders with Exclusive Whole... Mar 10 2015
    Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering Mar 07 2015
    Quest Diagnostics To Speak At The Barclays Global Healthcare Conference Mar 05 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK